US Orthobio market shines bright for the first quarter of 2023.
Among the many topics covered in detail in SmartTRAK's comprehensive Q123 US Orthobio Market Recap* are:
- Complete Q123 Orthobio Market Overview
- SmartTRAK's Expert Market Analysis and Insights
- All Orthobio Companies' News, Revenues, Data, Charts and Market Shares
- US Bone Replacement – Springing Back Into Light
- Growth Factors/Peptides
- DBM and Synthetics
- US Cartilage Replacement –The Light Continues To Shine Bright
- Cellular Grafts
- Osteochondral Grafts
- US Soft Tissue Replacement – Sunny Days Continue
- Soft Tissue Patches
- Tendon Allografts
- US Meniscus Replacement – Sun is Shining Back on The Market
Despite continued healthcare staffing shortages and economic uncertainties, the US Bone Replacement experienced high single-digit percentage growth in Q123 as it benefited from increased utilization, especially in ...
*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
